A Conference on Asbestos & Mesothelioma

Transcription

1 A Conference on Asbestos & Mesothelioma May 3 rd 4 th, 2010 Las Vegas, NV Encore, a Wynn Hotel Faculty Jerrold Abraham Wayne Berman David Bernstein Arnold Brody Andrew Churg David Egilman Murray Finklestein CO-CHAIRS Samuel Hammar, MD Director of Diagnostic Specialty Laboratories, Bremerton, WA Shepard A. Hoffman, Esq. The Hoffman Law Firm, Dallas, TX Robert A. Rich, Esq. Gordon & Rees, San Francisco, CA Victor L. Roggli, MD Professor of Pathology Duke University Medical Center, Durham, NC Doug Henderson Gunnar Hillerdal Allen Gibbs Graham Gibbs Howard Kipen William Longo Eugene Mark Corbett McDonald Julian Peto Frederick Pooley

2 Welcome to Perrin Conferences A Conference on Asbestos & Mesothelioma This unique conference brings together some of the world s best known asbestos researchers, physicians, and scientists to discuss ASBESTOS AND MESOTHELIOMA. Through a series of panel discussions we hope to foster interaction not only among the speakers but with the audience as well. To enhance networking opportunities, speakers will be seated with the audience during Monday s luncheon. Additionally, on Monday evening following the cocktail reception and logistics permitting, attendees will have the option to have dinner with the faculty.

3 Faculty Jerrold L. Abraham, MD, Professor of Pathology, SUNY Upstate Medical University, Syracuse, NY D. Wayne Berman, Ph.D., Researcher in asbestos exposure and risk, President of Aeolus, Inc., San Francisco, CA David Bernstein, Ph.D., Consultant in Toxicology, Geneva, Switzerland Professor Arnold R. Brody, Ph.D., Department of Molecular Biomedical Sciences, North Carolina State University, Raleigh, NC Andrew Churg, MD, Professor of Pathology, University of British Columbia, Vancouver, BC David Egilman, MD, MPH, Clinical Associate Professor, Department of Community Health, Brown University, Providence, RI Murray Finkelstein, Ph.D., MD, Associate Professor, Program in Occupational Health and Environmental Medicine, McMaster University and Department of Family Medicine, University of Toronto, Hamilton, ON and Toronto, ON, Canada Allen Gibbs, MD, Histopathology Consultant for the National Health Service, University Hospital Llandough, Penarth, South Wales, UK Graham W. Gibbs, MSc Ph.D., MRSC, ROH, President, Safety Health Environment International Consultants Corp. & Adjunct Professor, Department of Medicine, University of Alberta, Alberta, Canada Samuel Hammar, MD, Director of Diagnostic Specialty Laboratories, Bremerton, WA Douglas W. Henderson, MB, BS, FRCPA. FRCPath, FHKCPath, Professor of Anatomical Pathology, Flinders University, Adelaide, South Australia Gunnar Hillerdal, MD, Ph.D., Assistant Professor, Department of Lung Medicine, Karolinska Institute and University Hospital, Stockholm, Sweden Howard M. Kipen, MD, MPH, Professor and Interim Chair, Department of Environmental & Occupational Medicine Chief, Clinical Research & Occupational Medicine Division, UMDNJ-Robert Wood Johnson Medical School Piscataway, New Jersey

4 Faculty William E. Longo, Ph.D., President, Materials Analytical Services, Inc., Atlanta, GA Eugene J. Mark, MD, Professor of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA Corbett McDonald, MD, FRCP, Emeritus Professor (Epidemiology), McGill University; Emeritus Professor (Occupational Medicine), University of London, Montreal, QC, Canada Al Parnell, Esq., Hawkins, Parnell, Thackston, & Young LLP, Atlanta, GA Frederick David Pooley, Ph.D., CEng, Research Professor Pathology Department Medical Microscopy Science Laboratory, Cardiff University, Cardiff, Wales, UK Julian Peto, DSc FMedSci, Cancer Research UK Chair of Epidemiology, London School of Hygiene & Tropical Medicine, London, England Victor L. Roggli, MD, Professor of Pathology, Duke University Medical Center, Durham, NC

5 Event Agenda Day 1 Monday, May 3, :30 AM Continental Breakfast and Registration 8:15 AM Opening Remarks Samuel Hammar, MD, Director of Diagnostic Specialty Laboratories, Bremerton, WA Shepard A. Hoffman, Esq., The Hoffman Law Firm, Dallas, TX Robert A. Rich, Esq., Gordon & Rees, San Francisco, CA Victor L. Roggli, MD, Professor of Pathology, Duke University Medical Center, Durham, NC 8:30 AM Epidemiology: Part I Developments over the past 20 years Does epidemiology have a role in determining individual causation Strengths and weaknesses of epidemiology 10:00 AM Break 10:15 AM Epidemiology: Part II Developments over the past 20 years Does epidemiology have a role in determining individual causation Strengths and weaknesses of epidemiology 11:45 AM Lunch with Faculty 1:00 PM Pathology Developments over the past 20 years Pathology of pleural, peritoneal and pericardial mesothelioma Does pathology have a role in determining individual causation Strengths and weaknesses of pathology Moderator: Al Parnell, Esq., Hawkins, Parnell, Thackston, & Young LLP, Atlanta, GA 2:30 PM Break 2:45 PM Experimental Studies Experimental and animal toxicology studies Bio-persistence of asbestos Individual susceptibility In Vitro and Vivo studies 4:15 PM Cocktails

6 Event Agenda Day 2 Tuesday, May 4, :30 AM Continental Breakfast 8:00 AM Asbestos in Human Tissue Fiber burden studies: detection, evaluation, interpretation Asbestos fibers in lung, pleura and other organs SEM and TEM 9:30 AM Break 9:45 AM Minerology, Fiber Types & Sources Basic morphology and chemical makeup of asbestos Molecular biology of asbestos Sources of asbestos 11:15 AM Open Roundtable Discussion with Faculty and Audience 12:30 PM Adjourn Speakers & Agenda are subject to change.*